NATURAL HOLISTIC MEDICINE BLOG - The 2024 Phoenix Sepsis Criteria, initially developed to identify signs of sepsis in critically ill children, has emerged as a significant subject of scrutiny within the neonatal care community. According to a new study presented at the Society of Critical Care Medicine’s 2026 Critical Care Congress in Chicago, the Phoenix 8-point score demonstrated limited utility in identifying clinician-diagnosed sepsis in neonates. However, the data revealed a compelling finding: the score proved remarkably effective at predicting sepsis-related mortality in infants born prematurely.
This study, which provides a retrospective analysis of 3,045 neonates, addresses a critical gap in medical literature. The original Phoenix sepsis criteria, as detailed in JAMA (2024; 331[8]:675-686), explicitly excluded data from premature infants and those with hospital birth admissions, leaving clinicians uncertain about the score's applicability to the most vulnerable patient populations. As medical teams continue to seek robust, universal standards for pediatric sepsis, this research offers a nuanced perspective on how current tools function within the unique physiological landscape of the neonatal intensive care unit (NICU).
Evaluating the Phoenix 8-Point Score in Neonatal Populations
The retrospective analysis involved 3,045 neonates who were evaluated for sepsis within their first three months of life. Among this cohort, which was 57% male with a mean gestational age of 35 weeks, 791 infants (26%) ultimately received treatment for sepsis. When researchers applied the Phoenix-8 score to this group, the results were disparate regarding diagnostic and prognostic capabilities.
The analysis yielded an area under the receiver operating curve (AUROC) of 0.61 for predicting clinician-diagnosed sepsis, indicating that the tool was largely ineffective for initial diagnosis in this specific population. Conversely, the score demonstrated a strong performance in predicting mortality, with an AUROC of 0.81. This discrepancy highlights the complexity of identifying active infection in newborns compared to predicting the severity of the clinical trajectory once the illness has taken hold.
“The best performing organ subscores included respiratory, cardiovascular, coagulation, immunologic, and endocrine, which could be used to modify the criteria to best identify sepsis in neonates,” explained study co-author Karly Katchen, DO, a pediatric resident at Cohen Children’s Medical Center, in New Hyde Park, New York. Dr. Katchen emphasized that despite the profound differences in physiology and immune maturity between neonates and older children, the Phoenix Sepsis Criteria serves as a potent predictor of neonatal mortality.
The Diagnostic Challenge: Sepsis vs. Prematurity Complications
Distinguishing between true sepsis and the common complications associated with prematurity remains one of the most persistent challenges in neonatal medicine. Thomas Diacovo, MD, the vice chair of research and chief of neonatology at Stony Brook Children’s Hospital, in Stony Brook, New York, who was not involved in the study, noted that symptoms frequently overlap. Premature infants often present with organ system dysfunction, such as apnea or respiratory distress syndrome, which can be easily misinterpreted as signs of sepsis.
This diagnostic uncertainty was a primary factor in the exclusion of premature newborns from the original Phoenix sepsis score development. According to Dr. Diacovo, clinicians face a high-stakes scenario where the inability to quickly identify septic patients can lead to delays in life-saving interventions. “We need better screening tools to identify which patients are septic and which are not,” Dr. Diacovo stated. He cautioned that clinicians should never assume that clinical deterioration is solely a consequence of prematurity, as sepsis can quickly exacerbate existing vulnerabilities.
Implementing Clinical Protocols: The Role of Sepsis Huddles
While research into scoring systems continues, institutions are simultaneously adopting operational strategies to improve outcomes. Dr. Diacovo, who has prioritized earlier recognition of sepsis since assuming leadership of the neonatology division at Stony Brook three years ago, implemented "sepsis huddles." These huddles involve a multidisciplinary team—including the attending physician, fellow, bedside nurse, and nurse practitioner—whenever sepsis is suspected in an infant.
The huddle protocol focuses on observing subtle but vital changes in an infant’s clinical status, such as an increasing heart rate or the need for escalating temperature support. By gathering the care team, the hospital ensures that blood cultures are obtained rapidly and that critical interventions, such as the initiation of empiric antibiotics, IV fluids, and vasopressors, are not delayed. “More eyes and more experience improve recognition,” Dr. Diacovo explained, adding that the initiative has significantly reduced the severity of both culture-negative and culture-positive sepsis cases at his facility.
Looking Ahead: Artificial Intelligence and Precision Medicine
The quest for earlier and more accurate detection is increasingly looking toward the integration of technology. Dr. Diacovo expressed optimism regarding the potential for artificial intelligence-based algorithms to augment clinical decision-making in the NICU. As the stakes remain incredibly high—with Dr. Diacovo noting that "if you miss it, hours matter"—the convergence of refined clinical scores like the Phoenix criteria and predictive AI modeling may hold the key to better patient outcomes.
Current developments, including the focus on "precision" approaches to sepsis treatment, acknowledge that infection in newborns can result from distinct, complex causes. While clinicians continue to refine how they use scores like the Phoenix-8, the consensus remains that human expertise, supported by consistent, team-based communication protocols like the sepsis huddle, remains the frontline defense against the rapid progression of sepsis in the neonatal population.
The findings presented at the 2026 Critical Care Congress serve as a vital reminder that while existing criteria offer prognostic value, the clinical identification of sepsis in the NICU requires a customized, multifaceted approach. As research progresses, the medical community will likely see further modifications to these scores, potentially integrating the specific organ subscores that Dr. Katchen and her colleagues identified as most predictive for this vulnerable demographic.
Frequently Asked Questions (FAQ)
What is the Phoenix Sepsis Score?
The Phoenix Sepsis Score is a clinical tool, outlined in the 2024 Phoenix Sepsis Criteria, used to identify signs of sepsis in critically ill children. It calculates a cumulative total based on various clinical variables and organ dysfunction markers.
Did the study find the Phoenix score effective for neonates?
The study found that while the Phoenix-8 score was not effective at predicting clinician-diagnosed sepsis in neonates (AUROC 0.61), it was effective at predicting sepsis-related mortality (AUROC 0.81).
Why were premature infants originally excluded from the Phoenix Sepsis Criteria?
Premature infants were excluded because it is difficult to distinguish between sepsis and the complications of prematurity, such as apnea or respiratory distress syndrome, which can present with similar symptoms.
What are 'sepsis huddles' in the NICU?
Sepsis huddles are a clinical practice where the multidisciplinary care team—including the attending physician, fellow, bedside nurse, and nurse practitioner—meets immediately when sepsis is suspected to review the patient's condition, order tests, and initiate rapid treatment.
Can AI help improve sepsis detection in the NICU?
Experts, including Dr. Thomas Diacovo, are optimistic that AI-based algorithms can help improve early detection by monitoring for subtle physiological changes that may indicate the onset of sepsis.
Comments